Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19

J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9.

A-C Fougerousse¹, M Perrussel², P-A Bécherel³, E Begon⁴, V Pallure⁵, I Zaraa⁶, G Chaby⁷, J Parier^{8

9}, M Kemula^{10

11}, L Mery-Bossard¹², C Poreaux¹³, C Taieb¹⁴, F Maccari^{1

8}, Z Reguiai¹⁵; GEM Resopso

¹ Dermatology Department, Military Teaching Hospital Bégin, Saint Mandé, France.
² Private Practice Auray, Dermatology Department, University Hospital Rennes, Rennes, France.
³ Dermatology Department, Private Hospital, Antony, France.
⁴ Dermatology Department, Centre Hospitalier Pontoise, Pontoise, France.
⁵ Dermatology Department, Perpignan Hospital, Perpignan, France.
⁶ Dermatology Department, Saint-Joseph Hospital, Paris, France.
⁷ Dermatology Department, University Hospital, Amiens, France.
⁸ Private Practice, La Varenne Saint Hilaire, France.
⁹ Dermatology Department, Saint Louis Hospital, Paris, France.
¹⁰ Private Practice, Paris, France.
¹¹ Dermatology Department, Tarnier Hospital, Paris, France.
¹² Dermatology Department, Centre Hospitalier Intercommunal Poissy-Saint Germain en Laye, Poissy, France.
¹³ Private Practice, Nancy, Pasteur Clinic, Essey-les-Nancy, France.
¹⁴ Emma Clinic, Fontenay sous Bois, France.
¹⁵ Dermatology Department, Courlancy Polyclinic, Reims-Bezannes, France.

No abstract available

Publication types